Intel stock spikes after report of possible US government stake
BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), a leading provider of inpatient rehabilitation services, has announced a quarterly cash dividend of $0.17 per share. The dividend is payable on July 15, 2025, to shareholders of record as of July 1, 2025. According to InvestingPro data, the company has maintained dividend payments for 13 consecutive years, with a 13.3% dividend growth in the last twelve months.
This announcement follows Encompass Health’s consistent performance in the healthcare sector, operating 167 hospitals across 38 states and Puerto Rico. The company is recognized for its advanced technology and innovative treatments that contribute to the recovery of patients suffering from major injuries or illnesses. InvestingPro analysis shows the company maintains a "GREAT" Financial Health Score, with revenue growth of 11.2% and a robust gross profit margin of 42%.
Encompass Health’s commitment to quality care has earned accolades, including being named one of Fortune’s World’s Most Admired Companies™ and making the list of Forbes’ Most Trusted Companies in America. These acknowledgments reflect the company’s status in the healthcare industry and its dedication to excellence. The company’s strong performance is also reflected in its stock price, which is currently trading near its 52-week high, with a remarkable 42% return over the past year.
The declaration of the dividend is a testament to Encompass Health’s financial stability and its board of directors’ confidence in the company’s ongoing ability to generate shareholder value. Eight analysts have recently revised their earnings estimates upward for the upcoming period, according to InvestingPro’s comprehensive analysis, which includes detailed Research Reports available for over 1,400 US stocks. It is important to note that while the press release includes forward-looking statements regarding dividend payments, these are based on current estimates and subject to change due to various factors, including economic conditions and healthcare industry regulations.
Investors are reminded that such forward-looking statements involve risks and uncertainties, and actual results may differ from those anticipated. Encompass Health does not undertake any obligation to update these statements in light of new information or future events. Based on InvestingPro’s Fair Value analysis, the stock currently appears to be trading above its Fair Value.
This dividend announcement is based on a press release statement from Encompass Health and does not include any speculative or forward-looking commentary beyond what the company has publicly disclosed.
In other recent news, Encompass Health Corp reported strong financial results for the first quarter of 2025, surpassing analysts’ expectations. The company posted an earnings per share (EPS) of $1.37, exceeding the forecasted $1.20, and achieved revenue of $1.46 billion, above the anticipated $1.43 billion. This robust performance was driven by a 10.6% increase in revenue year-over-year and a 14.9% rise in adjusted EBITDA to $313.6 million. Following these results, Encompass Health raised its full-year guidance, projecting higher net operating revenue and EPS. Analysts at Mizuho Securities and RBC Capital Markets have responded positively to the company’s performance, with Mizuho raising its price target to $130 and RBC to $125, both maintaining an Outperform rating. The shift in payer mix, with Medicare Fee-For-Service volumes surpassing Medicare Advantage for the first time in three years, was noted as a significant development. Encompass Health’s strategic expansions, including the opening of new hospitals and bed additions, are expected to support future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.